[Combined evaluation of ovarian tumors with transvaginal B-image and color Doppler ultrasound]. 1996

H J Prömpeler, and H Madjar, and W Sauerbrei, and U Lattermann, and A Pfleiderer
Universitäts-Frauenklinik, Albert-Ludwigs-Universität Freiburg.

Transvaginal sonomorphologie and colour Doppler measurements were obtained preoperatively in 212 adnexal tumours: 81 premenopausal tumours (13 malignant and 68 benign) and 131 postmenopausal tumours (55 vs 76). Tumours were divided into five different scores according to their sonomorphology [16]. Scores I and II are related to benign tumours. Score V represents typically malignant tumours. Scores III and IV are associated with benign and malignant tumours. If score I and II are considered as benign and score III to V as malignant the sensitivity in pre- and postmenopausal tumours is 90%. However, the specificity is only 56% vs 70% respectively. In order to improve the accuracy, colour Doppler was additionally performed in tumours with sonomorphological score III and IV. The following criteria were tested: minimum resistance index (Rlmin), number of tumour arteries (ART), maximum (Smax) and sum (Ssum) of peak systolic velocities. All criteria showed significant differences between benign and malignant tumours. Tumours of score III and IV were differentiated by colour Doppler with an accuracy between 66% and 81% for premenopausal and 69% to 86% for postmenopausal women. The combination of sonomorphology and colour Doppler increased the accuracy between 84% and 90% with a sensitivity of up to 92% in pre- and 89% in postmenopausal patients. Sequential colour Doppler sonography as a supplement to transvaginal sonography improves tumour differentiation. The limitation of colour Doppler measurements to score III and IV lesions reduced the length of examination time to a reasonable extent.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001783 Blood Flow Velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. Blood Flow Velocities,Flow Velocities, Blood,Flow Velocity, Blood,Velocities, Blood Flow,Velocity, Blood Flow
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H J Prömpeler, and H Madjar, and W Sauerbrei, and U Lattermann, and A Pfleiderer
April 1996, Acta obstetricia et gynecologica Scandinavica,
H J Prömpeler, and H Madjar, and W Sauerbrei, and U Lattermann, and A Pfleiderer
January 1992, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology,
H J Prömpeler, and H Madjar, and W Sauerbrei, and U Lattermann, and A Pfleiderer
February 1992, Rinsho byori. The Japanese journal of clinical pathology,
H J Prömpeler, and H Madjar, and W Sauerbrei, and U Lattermann, and A Pfleiderer
January 2002, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti,
H J Prömpeler, and H Madjar, and W Sauerbrei, and U Lattermann, and A Pfleiderer
January 2004, European journal of gynaecological oncology,
H J Prömpeler, and H Madjar, and W Sauerbrei, and U Lattermann, and A Pfleiderer
January 1995, Journal of clinical ultrasound : JCU,
H J Prömpeler, and H Madjar, and W Sauerbrei, and U Lattermann, and A Pfleiderer
April 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
H J Prömpeler, and H Madjar, and W Sauerbrei, and U Lattermann, and A Pfleiderer
September 2003, European journal of obstetrics, gynecology, and reproductive biology,
H J Prömpeler, and H Madjar, and W Sauerbrei, and U Lattermann, and A Pfleiderer
August 1994, Gynecologic oncology,
H J Prömpeler, and H Madjar, and W Sauerbrei, and U Lattermann, and A Pfleiderer
June 1992, Gynecologic oncology,
Copied contents to your clipboard!